抽象的

Polypharmacy in Times of COVID-19: A Narrative Review

Shreya Gupta

COVID-19 pandemic caused by the SARS-Cov-2 virus, has become a serious public health concern worldwide which spread across more than 200 countries in a matter of months. Amidst a deadly second COVID wave in India, the resources and the health infrastructure required to handle the situation was stretched to their limits. Furthermore, due to the non-specific nature of the disease and the plethora of symptoms and complications it presents, the medical management of COVID-19 became complicated and uncertain. Such a grim scenario evokes fear and panic among the citizens, leading to questionable and unnecessary practices such as stocking of medicines, hoarding oxygen cylinders and most importantly, selfmedication with over-the-counter drugs, dietary supplements (so-called immune boosters), prescription-only drugs, along with combining the use of alternative systems of medicine. Due to all these reasons, the practice of ‘polypharmacy’ is becoming rampant among the general population, which in most cases is inappropriate and even harmful. This review summarizes the various patient and physician associated factors promoting polypharmacy, along with examples of the common drugs being prescribed and/or self-administered, and the various steps that can be taken to prevent such futile practices.

索引于

化学文摘社 (CAS)
哥白尼索引
打开 J 门
学术钥匙
研究圣经
引用因子
电子期刊图书馆
参考搜索
哈姆达大学
学者指导
国际创新期刊影响因子(IIJIF)
国际组织研究所 (I2OR)
宇宙
日内瓦医学教育与研究基金会
秘密搜索引擎实验室

查看更多